Fukoku Mutual Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$871K Buy
1,753
+356
+25% +$158K 0.05% 83
2026
Q1
$624K Hold
1,397
0.04% 82
2025
Q4
$633K Sell
1,397
-192
-12% -$82.8K 0.04% 93
2025
Q3
$622K Hold
1,589
0.04% 96
2025
Q2
$707K Sell
1,589
-226
-12% -$104K 0.05% 93
2025
Q1
$880K Sell
1,815
-40
-2% -$18.6K 0.07% 71
2024
Q4
$747K Hold
1,855
0.05% 84
2024
Q3
$863K Hold
1,855
0.06% 77
2024
Q2
$869K Sell
1,855
-166
-8% -$72.1K 0.07% 73
2024
Q1
$845K Sell
2,021
-119
-6% -$50.3K 0.07% 71
2023
Q4
$871K Sell
2,140
-500
-19% -$185K 0.07% 79
2023
Q3
$918K Buy
2,640
+500
+23% +$175K 0.08% 66
2023
Q2
$753K Hold
2,140
0.07% 75
2023
Q1
$674K Sell
2,140
-1,000
-32% -$300K 0.06% 81
2022
Q4
$907K Buy
3,140
+1,720
+121% +$524K 0.08% 73
2022
Q3
$411K Hold
1,420
0.04% 138
2022
Q2
$400K Sell
1,420
-30
-2% -$8.03K 0.03% 147
2022
Q1
$378K Sell
1,450
-100
-6% -$23.7K 0.03% 184
2021
Q4
$340K Buy
1,550
+60
+4% +$11.7K 0.03% 217
2021
Q3
$270K Sell
1,490
-210
-12% -$41K 0.02% 251
2021
Q2
$343K Hold
1,700
0.03% 185
2021
Q1
$365K Hold
1,700
0.04% 146
2020
Q4
$402K Hold
1,700
0.04% 136
2020
Q3
$463K Buy
1,700
+200
+13% +$55.2K 0.05% 120
2020
Q2
$435K Hold
1,500
0.05% 118
2020
Q1
$357K Hold
1,500
0.05% 112
2019
Q4
$328K Buy
1,500
+200
+15% +$40.5K 0.04% 177
2019
Q3
$220K Hold
1,300
0.03% 195
2019
Q2
$238K Hold
1,300
0.03% 176
2019
Q1
$239K Sell
1,300
-100
-7% -$18.5K 0.03% 165
2018
Q4
$232K Buy
1,400
+200
+17% +$34.7K 0.03% 170
2018
Q3
$231K Sell
1,200
-200
-14% -$35.6K 0.03% 193
2018
Q2
$238K Hold
1,400
0.03% 174
2018
Q1
$228K Hold
1,400
0.04% 173
2017
Q4
$210K Hold
1,400
0.03% 197
2017
Q3
$213K Sell
1,400
-100
-7% -$15.1K 0.03% 190
2017
Q2
$193K Hold
1,500
0.03% 210
2017
Q1
$164K Buy
1,500
+100
+7% +$8.8K 0.03% 209
2016
Q4
$103K Buy
1,400
+100
+8% +$8.14K 0.02% 252
2016
Q3
$113K Hold
1,300
0.02% 241
2016
Q2
$112K Hold
1,300
0.02% 246
2016
Q1
$103K Buy
1,300
+200
+18% +$18.1K 0.02% 252
2015
Q4
$138K Hold
1,100
0.02% 248
2015
Q3
$115K Buy
1,100
+500
+83% +$64.2K 0.02% 258
2015
Q2
$74K Hold
600
0.01% 300
2015
Q1
$71K Buy
600
+200
+50% +$24K 0.01% 298
2014
Q4
$48K Buy
+400
New +$45.1K 0.01% 309

Other funds holding VRTX

Fukoku Mutual Life Insurance's VRTX Position: Q2 2026 in Review

Fukoku Mutual Life Insurance increased its Vertex Pharmaceuticals (VRTX) stake by 25% in Q2 2026, buying an estimated $158K and bringing the position to 1,753 shares worth $871K. The position accounts for 0.05% of the portfolio, ranked #83.

Fukoku Mutual Life Insurance first reported a position in VRTX in Q4 2014 and has held it in 47 quarters since. The position peaked at $918K in Q3 2023. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Fukoku Mutual Life Insurance held 1,753 shares of Vertex Pharmaceuticals worth $871K as of Q2 2026.
  • Fukoku Mutual Life Insurance bought 356 Vertex Pharmaceuticals shares in Q2 2026, an estimated $158K.
  • Vertex Pharmaceuticals made up 0.05% of Fukoku Mutual Life Insurance's portfolio in Q2 2026, its #83 holding.
  • Fukoku Mutual Life Insurance first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 47 quarters since.
  • Fukoku Mutual Life Insurance's Vertex Pharmaceuticals position peaked at $918K in Q3 2023.
  • 484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fukoku Mutual Life Insurance's 13F filing for Q2 2026, filed 24 Jul 2026.